David Hung Insider Trading $NVCR NovoCure Ltd

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for David Hung.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of David Hung. David Hung is President and CEO in MEDIVATION, INC. ($MDVN) and Principal Executive Officer in Axovant Sciences Ltd. ($AXON) and Director in NovoCure Ltd ($NVCR) and Director in ESTABLISHMENT LABS HOLDINGS INC. ($ESTA) and Director in ARYA SCIENCES ACQUISITION CORP. ($ARYA) and President and CEO in Nuvation Bio Inc. ($PANA).

David Hung in NovoCure Ltd

Trading Symbol: NVCR
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of David Hung: Director
Holdings: 5,900 shares
Current Value: $40,120
Latest Transaction: Jun 12 2020
$NVCR Market Capitalization: $581.43M
$NVCR Previous Close: $6.80

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of David Hung in NovoCure Ltd

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ARYA, ESTA, MDVN, NVCR, NUVB, AXON

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 12 2020NVCRNovoCure LtdHung DavidDirectorOption ExerciseA67.895,101346,3075,101
Jun 12 2020NVCRNovoCure LtdHung DavidDirectorGrantA0.002,54105,9003.4 K to 5.9 K (+75.65 %)
Jun 04 2018NVCRNovoCure LtdHung DavidDirectorOption ExerciseA31.4545,1371,419,55945,137
Jun 04 2018NVCRNovoCure LtdHung DavidDirectorOption ExerciseA31.4545,1371,419,55945,137

Page:   1